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Abstract: Advancements in veterinary medicine have resulted in an increased number of
geriatric horses being presented for medical or surgical procedures that require general anesthesia.
Due to the physiological changes associated with aging and the likelihood of concurrent disease
conditions, the geriatric equine is at an increased risk during anesthesia. The main physiological
changes associated with aging, and their impact on anesthesia, are discussed in this review.
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Aging is not simply the passage of time, but a physiological, irreversible, and
progressive process characterized by degenerative changes in the structure and
functional reserve of organs and tissues,1 and can be defined as the loss of ability
to adapt to a changing environment.2 Recent advances in veterinary medicine have
increased the number of geriatric horses being presented for surgical or diagnostic
procedures that require general anesthesia. Older horses are more likely to suffer
from gastrointestinal emergencies, dental disease, neoplasia, sinus infections and
ethmoidal hematomas, esophageal choke, and ocular problems. Data from Colorado
State University Veterinary Teaching Hospital reported an increase in the percentage
of horses 15 years or older being admitted for treatment, from 3% in 1973 to 12%
in 2000.3
The characterizations of age include the chronological age, or how many years
an animal has been alive; the physiologic age, or how well the animal is functioning
in comparison to a younger animal; and the demographic age, or how the animal
compares chronologically with other animals of the same species.3 Clearly, due to the
presence of concomitant or age-related diseases and environmental factors, there is a
large variability in physiological status among the geriatric population. Additionally,
horses may be considered different from humans or small animals as they need to
remain physically active in their day-to-day existence; therefore, the term functional
age is used to take into account the horse’s use.4
The age at which a horse is considered aged is unclear, and depends on many
factors. As a general guideline based on the chronological age, animals in the last
25% of the predicted life span for the species and breed are considered aged. Based
on the average life span of horses and ponies (25 and 30 years, respectively),5 studies
have considered horses to be geriatric at 20 years of age.6–8
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Physiology of aging
Although increasing age should not be considered a disease
state per se, aging impedes the body’s ability to cope with
stress; consequently, aging individuals undergo physiological
changes that may impact how they respond to anesthesia.9,10
Generally, in aged humans and animals, the physiological
reserve and therefore, the ability of the body to maintain
homeostasis decreases. Almost every body system is affected
by aging, and many of these changes may affect the pharmacokinetics and pharmacodynamics of anesthetic drugs.
Most information on the physiology of aging is based
on research performed on laboratory animals and humans.
Although little is known specifically about the effects of
aging in horses, there is no reason to suspect that horses
differ from other species in this regard. It seems that no single
cause is responsible for aging – aging is considered to be a
multifactorial process,11 and many processes may interact
simultaneously.12

Theories of aging
A number of theories have been formulated to explain the
aging process, and can be categorized as evolutionary,
molecular, cellular, and systemic theories. The evolutionary
theory states that aging results from a decline in the force of
natural selection, and longevity is a trait to be selected only if
it is beneficial for fitness. The molecular theory proposes that
senescence is caused by changes in gene expression,13 and
that aging primarily results in damage to genetic material. The
cellular theory encompasses theories relating to cellular and
telomere senescence, free-radical damage to lipids, proteins,
and DNA, and apoptosis subsequent to genetic events or
genome crisis. The system-based theory of aging ascribes the
aging process to a decline in the function of essential organs,
such as in the neuroendocrine and immune systems.
Overall, mitochondrial dysfunction and oxidative stress
are considered the two main interdependent mechanisms
responsible for cellular damage and aging. Oxidative stress,
initiated and propagated by various free radicals, not only
damages the phospholipid, protein, and DNA molecules
within the cell, but also modulates cell signaling pathways
and gene expression patterns.14

Aging and the nervous system
In humans, aging causes a decrease in neural density and
loss of up to 30% of brain mass by the age of 80 years.1 In
a study of the brains of horses aged 7–23 years, significant
microscopic changes, that appeared to be similar to those
described in elderly people, were observed. These changes
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were indicative of neuronal damage and depletion, and
arterial wall degeneration.15 Similar nervous system changes
may be responsible for cognitive dysfunction in elderly
humans.16,17 Although it is difficult to identify cognitive
dysfunction in horses, it has been stated that older horses
respond more slowly to stimuli than do younger horses.5
In elderly humans, cerebral blood flow is reduced by
10%–20%, in response to a decrease in cerebral metabolic
rate and decreased cerebral mass. There is a depletion of
neurotransmitters including catecholamines, serotonin, and
acetylcholine. Dopamine uptake sites, transporters, and their
concentration are decreased, as are cortical serotonergic,
alpha-2, beta adrenergic, and gamma-aminobutyric acid
(GABA) binding sites, and this may affect memory and motor
function.1,18 Depletion of nervous system neurotransmitters
and receptor density has not been evaluated in elderly
horses; however, the response of the cardiovascular system
to inotropic agents was reported to be similar to that in
younger animals.19
The peripheral nervous system goes through ageassociated changes including loss of motor, sensory and
autonomic fibers, a decrease in afferent and efferent
conduction velocities, and progressive decline of signal
processing rate. A decrease in the efficiency of nerve to
muscle coupling, and the number of muscle cells innervated
by an axon, may lead to denervation and muscle atrophy.
The responsiveness of autonomic end organs is decreased
in elderly people, despite an increase in plasma epinephrine
and norepinephrine concentrations.1 However, in a study
on old beagles, aging did not alter the responsiveness of
postsynaptic adrenergic and nonadrenergic receptors in
the skeletal–muscle vasculature of the canine hind-limb,
in comparison with young animals.20 In the same study,
the expression of adrenergic and nonadrenergic receptors
in skeletal muscle arteries was also largely unaffected by
aging. Thus, animals may differ from humans with regard
to peripheral nervous system changes.
Human studies have indicated only subtle changes in
blood–brain barrier function in geriatrics;21 nevertheless,
studies in humans and animals indicate a decrease in the
minimum alveolar concentration (MAC) of inhalational
anesthetics with advancing age.22,23 The decrease in MAC may
be due to several mechanisms including pharmacodynamic and
pharmacokinetic alterations.24 For instance, increased blood/
gas solubility of inhalational anesthetics and some biochemical
alterations such as lower plasma albumin concentration in
geriatrics may have a role.22,25,26 The anesthetic MAC has
not been studied in geriatric horses; however, a study in dogs
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indicated a decrease in the MAC of isoflurane in older dogs,
and this has been ascribed to changes in N-methyl-D-aspartate
(NMDA) receptor binding.27
Postoperative cognitive dysfunction (POCD) has been
described in up to 50% of human patients undergoing
anesthesia, though most seem to recover with time. Increasing
age, duration of anesthesia, a second operation, postoperative
infections, and respiratory complications are risk factors
for early POCD, but age was found to be the only risk
factor for late POCD.28,29 Although there is no evidence for
the occurrence of POCD in geriatric horses, some forms
of POCD may be expected to occur in geriatric horses
because anesthetic complications, such as hypoxemia and
hypotension, are common in this species.
There is no specific protocol for the prevention of
anesthetic-related insults to the nervous system; however,
it is plausible that maintaining perioperative homeostasis as
close to normal as possible may minimize the risk of central
nervous imbalances resulting from general anesthesia.

Aging and the cardiovascular
system
Some anomalies, such as valvular heart disease, are more
prevalent in older horses; whereas, myocardial disease and
pericarditis are not.30,31 Many of these abnormalities are
well tolerated clinically, and are not necessarily associated
with an increased risk of death; but, in a proportion of older
horses, they may lead to signs of severe cardiac dysfunction.
It should also be noted that horses with congenital lesions,
such as ventricular septal defect or patent ductus arteriosus,
may not develop signs of heart failure until later years.30 In
a prospective cohort study in horses, it was reported that
although the prevalence of all causes of death increased with
age, cardiovascular deaths did not occur in horses younger
than 15 years of age, and the prevalence of fatality due to
cardiovascular diseases was 5.1% in the 15–23-year-old
group and 8.5% in the 24-year-old and older group.32
In humans, aging results in an overall decrease in the
tonic influence of the parasympathetic nervous system,
a decline in the responsiveness of beta receptors, and the
replacement of compliant cardiac and vascular tissue by
a stiff, fibrotic tissue. These changes blunt chronotropic
and inotropic responses of the heart, and impair diastolic
filling. Consequently, the ability of the older patient to
cope with stress is compromised.33,34 Equine hearts have not
been studied as thoroughly, but fibrous scarring of the left
ventricular apex is reported to occur in 60% of hearts from
horses older than 20 years of age.35 Decreased ventricular
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compliance decreases diastolic filling, increases end-diastolic
pressure, and makes the heart volume sensitive and volume
intolerant, and may affect cardiac output.1,36 However, the
degree to which aging is associated with a decrease in cardiac
output and stroke volume at rest is controversial. Decreases of
up to 5% per decade in these parameters have been described
in humans and, at the age of 80 years, are decreased by 50%
when compared to a 30-year-old.1,34
Functional cardiac studies in horses have demonstrated
that maximal heart rate (HRmax) and aerobic capacity decline
with age.37,38 The decline in HRmax may limit maximal cardiac
output and, thus, maximal oxygen consumption (VO2max)
and the ability to perform exercise. A decline in VO2max and
exercise capacity with aging has been reported in horses.37

Valvular heart diseases
Valvular heart disease is the most common form of cardiac
disease in the horse, with an overall prevalence of 23%, and
the prevalence seems to be greater in horses 16 years of
age or older.39 Aortic valve pathology accounts for 82% of
valvular abnormalities, and the greatest incidence of aortic
regurgitation is in horses aged 15–20 years.40 Horses with
aortic insufficiency also appear to be at risk of developing
supraventricular and ventricular arrhythmias. These
arrhythmias are rarely recognized on physical examination,
and require ambulatory and exercising electrocardiographic
studies to document their presence.30 Other arrhythmias, such
as ventricular premature beats or ventricular tachycardia,
may reflect myocarditis.41 S-T segment depression has been
reported in horses with chordae tendineae rupture, and may
indicate myocardial ischemia.31 The prevalence of these
arrhythmias during anesthesia in older horses and their impact
on cardiovascular physiology has not been investigated.
The incidence of mitral insufficiency is not greater in
older horses,41 but the intensity of murmurs due to mitral
insufficiency is reported to be greater in older horses.30 In a
substantial proportion of horses presenting with severe mitral
insufficiency, there is concurrent myocardial fibrosis and, in
some of these animals, myocardial lesions are considered
to be the primary disease leading to mitral insufficiency.41
Another study indicated that age was a significant risk factor
for mortality associated with aortic and mitral insufficiency.32
Increases in left atrial pressure secondary to mitral
regurgitation may result in an increase in left atrial diameter,
and these horses have an increased risk of developing atrial
fibrillation.31 Horses with pulmonary hypertension, as a
sequela of mitral regurgitation, are at risk for sudden death
secondary to rupture of the pulmonary artery.41
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Aortocardiac fistula
Aortocardiac fistula, although first described as a disease
of older stallions, is not unique to older horses.30,42,43 The
etiology of this condition is unclear, but it occurs as a result
of rupture of the right aortic sinus. The aorta ruptures directly
into the right atrium or ventricle or forms a fistulous tract
through the aortic ring or ventricular septum to the left or
right ventricle or right atrium. Stallions older than 5 years
of age are most commonly affected.43

Age-associated vascular changes
In aged humans, the vascular system is affected by a decrease
in the tonic influence of the parasympathetic nervous system,
and changes in the vascular wall.33,34 Vascular changes
result in arterial and venous rigidity, an increase in systemic
vascular resistance, and a decrease in venous compliance.
Mineralization of the intimal layer of blood vessels is a
common finding in the cerebral arteries, capillaries, and veins
of old horses, although its clinical importance is not clear.44
The loss of elasticity in large arteries causes a progressive
increase in systemic blood pressure and widening of pulse
pressure. Increased sympathetic nervous system activity may
also contribute to the increase in systemic vascular resistance.
Age-associated vascular changes in horses are not well
documented; however, in one study, there was no difference
in arterial blood pressures in horses less than 15 years and
those over 20 years.5
A decrease in venous compliance decreases the ability
to compensate for changes in intravascular volume, and
exaggerates hypotension resulting from blood loss, or
from peripheral pooling of blood observed during general
or regional anesthesia. 45,46 Other factors predisposing
to hypotension may include diminished sensitivity of
baroreceptor and beta receptors’ response, and decreased
response of the renin/aldosterone/angiotensin system in
advanced age. 45,47 Hypotension is one of the common
complications during equine general anesthesia and these
vascular changes may further predispose the geriatric horse
to hypotension. However, in anesthetized horses, age did
not have an effect on the response to dobutamine therapy,
indicating that there was no decrease in the responsiveness
of beta receptors.19 Nevertheless, preliminary data indicates
that geriatric horses are more prone to the cardiovascular
depressant effects of inhalational anesthetics.5

Aging and the pulmonary system
Several anatomical and physiological changes in the
pulmonary system occur with aging. The main changes
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are increased compliance and decreased elastic recoil
of the lungs, and decreased respiratory muscle function
and chest wall compliance. Decreased chest compliance
and lung recoil increases residual and closing volumes, and
dead space ventilation. In elderly people, the dynamic lung
compliance becomes frequency dependent. As breathing rate
increases, lung expansion becomes less effective and ventilation to perfusion (V/Q) mismatch increases.1 A similar
pathophysiology may be responsible, at least in part, for
development of V/Q mismatch in geriatric horses. These
changes, along with a decrease in alveolar surface area and
an increase in shunting, result in decreased gas exchange
efficiency, decreased arterial oxygen partial pressures
(PaO2), and greater alveolar-arterial oxygen difference (A-a
difference).4,5 Decreased PaO2 and greater (A-a) O2 difference were reported in awake horses older than 20 years of
age when compared to a group of younger horses.8 In that
study, PaCO2 values in older horses were less, and the pH
was greater, compared to the younger animals, indicating a
compensatory hyperventilation.
In the elderly, loss of respiratory muscle fibers and a
decrease in central and peripherally mediated ventilatory
responses to changes in PaO2 and CO2 or airway stimulation have been reported,48 and are likely to occur to some
degree in older horses. 4,5 In recumbent horses under
inhalational anesthesia, functional residual capacity and
residual volume are reduced, and PaO2 values are often
decreased, despite the use of maximal fraction of inspired
oxygen.49,50

Recurrent airway obstruction
Recurrent airway obstruction (RAO) (heaves) is the most
common respiratory disorder in older horses. 51,52 This
recurrent inflammatory condition can cause permanent
pulmonary remodeling and fibrosis, if not treated initially.
Airway smooth muscle and pulmonary epithelial hypertrophy
may result in a net loss of intra-alveolar septae and pulmonary
capillaries, with an increased number of intra-alveolar
pores and deposition of collagen. Exercise intolerance,
respiratory distress, chronic coughing, mucopurulent nasal
discharge, abnormal pulmonary sounds, and an enlarged
field of percussion are usually noted during physical
examination. In these animals, pulmonary arterial pressure
is increased, gas exchange is compromised, and end-expired
lung volume is increased.53,54 Due to an overall decrease in
respiratory functional reserve, greater (A-a) O2 difference
and V/Q mismatch, and lower PaO2 and PaCO2 values
in geriatric horses, 8 perioperative pulmonary function
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is of particular concern. The PaO2 is usually decreased,
indicating impairment of pulmonary gas exchange. Therefore,
providing mechanical ventilation during general anesthesia
may correct blood gas abnormalities. As these horses usually
suffer from increased pulmonary resistance, bronchodilators
(beta-2 adrenergic agonists and parasympathomimetics)
are efficacious in relieving smooth muscle contraction in
the lower airways and the associated respiratory distress.55
The administration of bronchodilators, such as aerosolized
albuterol,56 during anesthesia may improve oxygenation
and ventilatory parameters. Recently, however, it has been
shown that the S-enantiomer of salbutamol can elicit an
increase in the contraction of equine airway smooth muscle
on isolated equine bronchi; thus, only the R-enantiomer is
recommended for use.57

Infectious pulmonary diseases
Although bacterial pneumonia is independent of age, geriatric
horses suffering from subclinical or undiagnosed pituitary
pars intermedia dysfunction (PPID) and increased serum
cortisol, are more prone to secondary bacterial pneumonia
due to immunosuppression. Bacterial pulmonary disease
may also occur secondary to upper airway viral pathogens
and RAO.

Aging and the musculoskeletal
system
Musculoskeletal diseases are among the most commonly
reported clinical problems in aged horses.58 Periarticular
degenerative diseases of the axial skeleton in aged horses
may be sufficiently advanced to compromise spinal cord
function. 35 Osteoarthritic degenerative changes affect
the overall function of the musculoskeletal system, and
may compromise the quality of recovery from general
anesthesia.
The loss of skeletal muscle and lean body mass that
occurs with aging is referred to as sarcopenia.59 Sarcopenia
encompasses the effects of changes in central and peripheral
nervous system innervation, hormonal status, inflammation,
altered caloric and protein intake, and cumulatively results in
loss of muscle fiber and fiber atrophy.2,60 Sarcopenia is only
now being recognized in veterinary patients.61 In humans,
age-associated changes in muscle strength are directly
correlated with the loss of skeletal muscle mass. A decrease
of approximately 40% in total muscle cross-sectional area
occurs in humans between the ages of 20 and 60 years.62,63
Significant age-related changes responsible for loss of muscle
mass and strength may include changes in motor units,
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muscle fibers, and muscle protein.64–67 These changes affect
spatial organization and physiological properties of fast- and
slow-twitch single motor units, regulation of contractile speed
and force generation capacity of muscle fibers, and functional
properties of myosin.68 There is also a disorganization of
coordinated expression of contractile, sarcoplasmic reticular
and mitochondrial protein isoforms in aging skeletal
muscle.64 The net effect of aging on neuromuscular function
is a reduction in contractile strength, proprioception, and
coordination.
It is clear that many older horses lose muscle mass;
h owever, many others remain active and appear well
muscled. Decreased muscle mass in a horse will have a
significant impact on the anesthetic outcome, as the horse’s
ability to stand during recovery may be compromised.
Sarcopenia may also contribute to increased heat loss under
general anesthesia. Lean animals lose core temperature faster
than animals with sufficient muscle mass, and this is well
demonstrated in elderly humans.69

Aging and the endocrine system
Cushing’s disease (pituitary pars
intermedia dysfunction – PPID)
Cushing’s disease, one of the most common endocrine
abnormalities of older horses, is the consequence of glucocorticoids acting in excess of physiological requirements.70
The prevalence of Cushing’s disease has increased during
the past several years and has an incidence of 0.5%. It is
primarily observed in horses 18–21 years old.71 Horses with
Cushing’s may be more sensitive to sedatives and anesthetics
as a consequence of muscle wasting and fat redistribution.
Also, corticosteroid-induced changes such as hepatopathy,
immunosuppression, and osteoporosis may affect drug
metabolism, pulmonary function (due to pneumonia), and
the quality of recovery.71,72
Cardiopulmonary changes such as tachypnea, tachycardia,
and hypertension are not uncommon in horses with
Cushing’s disease. 72 The vascular smooth muscle may
be more responsive to catecholamines,73 and some of the
cardiovascular instability present in geriatric animals may
be counteracted in animals with Cushing’s disease due
to an overall increase in sensitivity of the cardiovascular
system to adrenergic agents. However, vasoconstriction
and hypovolemia may result in reduced tissue perfusion,
and volume-loading of these animals prior to anesthesia is
recommended.5 Secondary diabetes mellitus or insipidus,
blood glucose, fluid, and electrolyte abnormalities may
also be present in these horses, and hyperhidrosis may
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contribute to the hypovolemia and hypokalemia.70,72 Due to
the catabolic effect of corticosteroids, these horses may be
sarcopenic, thus, supporting ventilation and recovery may
be necessary.5 Dopamine agonists or serotonin antagonists
are used to treat Cushing’s disease, and adverse effects such
as hypotension, agitation, cardiac arrhythmias, and sedation
have been reported with treatment.74–76

Hypothyroidism
Hypothyroidism is associated with aging in horses.4 Primary
hypothyroidism, as an autoimmune disease, has been reported
in specific instances in horses.70 Secondary hypothyroidism may
be due to hyperadrenocorticism or surgical thyroidectomy.70,72
Physiological changes after surgical thyroidectomy in horses
may include decreases in resting heart rate, cardiac output,
respiratory rate, and body temperature, and slight increases in
plasma and blood volume may be observed. Hypothyroidism
may contribute to bradycardia and hypotension during anesthesia, and the beta adrenergic responses may also change, as
the heart rate increase in response to isoproterenol was less in
horses after thyroidectomy.77
Identification and treatment of the underlying cause (if
any) of secondary hypothyroidism should be performed prior
to anesthesia. Although thyroid hormone supplementation
in horses is of unknown benefit, it may be beneficial in
secondary hypothyroidism.78
In summary, full evaluation of endocrine abnormalities
and correcting the imbalances should be performed prior to
anesthesia, particularly for elective procedures.

Pharmacological considerations
in geriatrics
The pharmacokinetics of anesthetic drugs in geriatric animals
may be altered by changes in physiological parameters such
as a decreased metabolic rate and cardiac output, increased
ratio of fat to muscle tissue, decreased cerebral blood flow,
a decrease in the concentration of plasma protein, and volume
of distribution of particular drugs.79,80 In older people, smaller
initial volumes of distribution and slower intercompartmental
clearance rates, redistribution, metabolism, and excretion for
propofol and thiopenthal are reported, and as much as a 50%
decrease in the dose may be indicated.79,81,82 It is suggested
that geriatric horses may experience more intense and longer
lasting analgesia with butorphanol and morphine for standing
sedation.5 The decreased lean body mass in geriatric animals
will cause a smaller amount of the drug to be directed into the
muscles;83 thus, a greater fraction of the drug will reach the
brain. There is a paucity of information on the effect of aging
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on these parameters in horses; but total protein and albumin
concentrations in several groups of horses older than 20 years
of age were similar to those of young horses.6,7
The pharmacodynamics of anesthetic drugs may be
altered in geriatric animals due to changes in receptor
sensitivity. Alterations in receptor activity of opioids
and benzodiazepines have been documented in geriatric
people.79,84 For instance, binding of the channel protein
associated with NMDA receptors increases with age,85 and
occupied benzodiazepine receptors create a relatively greater
depression of neuronal activity.80 Age-related changes in
brain NMDA receptor binding and a decrease in the MAC of
isoflurane have been demonstrated in geriatric dogs.27
Clearance of most anesthetics is prolonged in the
elderly.79 Recovery from anesthesia may be prolonged due
to decreases in drug clearance and tissue perfusion, and a
greater proportion of adipose tissue, which acts as a ‘sink’
for lipid soluble drugs.
A decrease in liver blood flow during anesthesia
may also have a significant effect on the clearance of
drugs with a high extraction ratio (eg, ketamine and
morphine), because hepatic clearance is proportional to
liver blood flow.79,86,87 In contrast, the clearance rate for
anesthetic drugs with a low extraction ratio (eg, diazepam
and thiopental) is limited by the metabolizing capacity
of the liver.86 Hepatic clearance of benzodiazepines is
slower in aged people;88 thus, repeated or large doses of
benzodiazepines may prolong recovery.
There is an age-associated increase in sensitivity to
opioids and a linear decrease in epidural dose requirements
in people. 89 Factors such as the anatomical changes
influencing the size and patency of the intervertebral
foramina, alterations in local blood flow, and changes
in nerve fibers and their integuments inside and outside
the spinal cord, are potential reasons for the difference in
pharmacodynamics of epidurally administered opioids. This
may also be the case in geriatric horses, as it was reported
that a 25-year-old horse with an infected pelvic limb tendon
sheath, required a smaller than expected dose of epidural
morphine to control pain.5
Renal clearance of drugs may also be affected by the
aging process, and although serum creatinine concentrations
may be within the normal range in geriatric people, creatinine
clearance may be decreased,79 indicating decreased renal
reserve. In a study of healthy horses older than 20 years, no
abnormality in serum urea nitrogen, creatinine, albumin, liver
enzyme activities, and electrolytes was found;7 creatinine
clearance was however, not measured.
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Anesthetic considerations
in geriatric horses
Anesthetic morbidity and mortality
in geriatrics
In humans, anesthetic associated morbidity and mortality
increase with aging,1 and the same is true for horses. In a
study of more than 41,000 horses, those aged 14 years or
older were at greater risk of mortality (odds ratio of 1.42).90
The two main reasons for increased mortality in older horses
were an increased risk of long-bone fracture during recovery,
and an increased likelihood of co-existing diseases affecting
the outcome.90 In another study on more than 17,000 horses
undergoing general anesthesia, there were 42 (0.24%)
perianesthetic fatalities.91 Although the relationship between
age and mortality was not evaluated as a covariant in that
study, the six Thoroughbred mares that fractured a long-bone
during recovery were older (9–18 years). Older mares may
be at an increased risk of long-bone fracture, as bone density
studies have reported decreased metacarpal breaking strength
in some older mares up to 40 weeks post-parturition.92

Preanesthetic evaluation of the geriatric
horse
After obtaining a complete history of use, exercise tolerance,
and ability to rise from recumbency, a thorough physical
examination should be performed. A physical examination
during rest and exercise has been suggested, because exercise
may unmask diseases such as RAO and cardiac diseases that
are not apparent at rest. In clinically healthy geriatric horses,
the authors perform only basic laboratory tests (hematocrit and
total protein determination); however, in sick horses a complete
and differential blood count and biochemical analysis may be
indicated. If significant cardiac murmurs or arrhythmias are
present, a complete cardiac evaluation is recommended.

Standing sedation
Many procedures, such as surgery of sinuses, dental surgery,
and laparoscopic surgery can be performed with the horse
standing and sedated, in association with local or regional
anesthesia. Standing surgery avoids the problems associated with general anesthesia and recovery, and should be
performed, whenever possible, in geriatric horses.

Drugs used for sedation
Acepromazine

Does not give reliable sedation, and may cause hypotension,
especially if large doses are used. Acepromazine has been
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mainly replaced by alpha-2 agonists, but small doses
(0.02 mg/kg, IV) can be combined with an alpha-2 agonist
for more profound sedation and analgesia.4

Opioids
Opioids such as butorphanol, morphine, and meperidine,
are not used alone for sedation because they may cause
dysphoria or excitement, especially if given as a bolus IV
to an unsedated horse; however, they have synergistic or
additive analgesic and sedative effects with other drugs such
as alpha-2 agonists. Therefore, opioids are usually combined
with alpha-2 agonists, as described below. Additionally,
histamine release and hypotension may result, especially if
meperidine is administered IV.

Alpha-2 agonists
This group of drugs provides dose-dependent sedation and
analgesia, thus, they can be administered to effect. They also
have the advantage of being reversible. In geriatric horses, the
authors initially administer a small dose of an alpha-2 agonist
(eg, xylazine 0.25–0.5 mg/kg, IV). Xylazine is the shortest
acting alpha-2 agonist and, thus, may be most suitable for use
in geriatric horses. Short-term sedation is usually achieved
by administering an alpha-2 agonist as a bolus; however,
a constant rate infusion (CRI) will give more reliable sedation
for prolonged procedures. To provide more reliable sedation
and analgesia, an alpha-2 agonist can be combined with
an opioid. The alpha-2 agonist bolus dose depends on the
degree of sedation and analgesia required, and IV doses in
the following ranges are recommended by the authors:
• Xylazine (0.25–1 mg/kg)
• Detomidine (0.0025–0.01 mg/kg)
• Romifidine (0.025–0.1 mg/kg)
• Dexmedetomidine (0.0015–0.0025 mg/kg).
If combining alpha-2 agonists with an opioid, it is
important that the horse is sedated before the opioid is
administered, to prevent opioid-induced excitement. In
addition, it is important to administer the drugs slowly, and in
increments, to achieve the desired effect and avoid excessive
sedation and ataxia.
The authors suggest the following IV drug doses when
combining alpha-2 agonists and opioids:
• Xylazine (0.25–1.0 mg/kg) plus butorphanol (0.01–
0.02 mg/kg) or morphine (0.1 mg/kg)
• Detomidine (0.0025–0.005 mg/kg) plus butorphanol
(0.01–0.02 mg/kg) or morphine (0.1 mg/kg)
• Romifidine (0.03–0.06 mg/kg) plus butorphanol (0.01–
0.02 mg/kg) or morphine (0.1 mg/kg)
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• Dexmedetomidine (0.001–0.002 mg/kg) plus butorphanol
(0.01–0.02 mg/kg) or morphine (0.1 mg/kg).

Constant rate infusions
Constant rate infusions (CRI) are used to deliver sedativeanalgesic drugs when prolonged sedation-analgesia is
required, as when surgery is performed on a standing horse.
A CRI provides a more steady state of sedation than intermittent
bolus administration of a drug(s). A CRI can be delivered by
adding the drug(s) to a bag of balanced electrolyte solution
and determining the drip rate; however, to be more accurate,
the drugs can be delivered using a syringe pump or fluid
pump. A loading dose (Ld) is delivered initially, and the
CRI is then started. Alpha-2 doses in the following ranges
are recommended:
• Xylazine: Ld = 0.25–1 mg/kg IV and a CRI =
0.5–1.0 mg/kg/hour
• Detomidine: Ld = 0.0025–0.01 mg/kg IV and a
CRI = 0.01–0.02 mg/kg/hour
• Dexmedetomidine: Ld = 0. 0015–0.0025 mg/kg IV and
a CRI of 0.0015–0.0025 mg/kg/hour
• Romif idine: Ld = 0.03–0.1 mg/kg IV and a
CRI = 0.01–0.02 mg/kg/hour.
If an opioid is added, the dose of the alpha-2 agonist is
decreased to avoid excessive sedation and ataxia. Doses in
the following range are used by the authors:
• Detomidine: Ld = 0.0025–0.005 mg/kg IV and a
CRI = 0.01 mg/kg/hour, plus
• Butorphanol: Ld = 0.01–0.02 mg/kg, IV and a
CRI = 0.012 mg/kg/hour or morphine: Ld = 0.10 mg/kg,
IV over 10 minutes, and a CRI = 0.15 mg/kg/hour.
Detomidine is the most frequently used alpha-2
agonist, but others may be used in place of detomidine.
For most procedures lasting less than 2 hours, the authors
just use a loading dose of morphine without a CRI. It is
especially important in geriatric horses that the loading
dose of morphine be administered slowly to avoid excessive
sedation.

effective half-life of yohimbine is about 1 hour, and this
prevents relapse of sedation in most horses.93 The affinity
of atipamezole for alpha-2 receptors is 100 times greater
than that of other antagonists, and the authors use a dose of
0.02–0.04 mg/kg, IV over 10 minutes.

Induction of anesthesia
There are a limited number of drug combinations for
induction of anesthesia. Although it may be best to administer
induction drugs to effect, the size of the horse makes this
impractical. In any case, geriatric horses tolerate induction
of anesthesia quite well if cardiovascularly stable.

Induction regimens

Ketamine and a benzodiazepine
This is the most common regimen for induction of anesthesia,
after sedation with an alpha-2 agonist (eg, xylazine 0.5–
1.0 mg/kg). For this purpose, ketamine (1.5–2.2 mg/kg)
and diazepam or midazolam (0.02–0.1 mg/kg) can be
combined in the same syringe and administered as a bolus.4
The benzodiazepine improves muscle relaxation and
sedation.

Guaiphenesin and ketamine
Guaiphenesin, a centrally acting muscle relaxant, is generally
administered as a 5% solution. It is used to facilitate induction
of anesthesia in the sedated horse, and many clinicians
include guaiphenesin in the regimen in order to decrease the
dose of alpha-2 agonist. Guaiphenesin can be administered
by one of two methods: after the horse becomes sedated,
guaiphenesin (30–50 mg/kg, IV) is administered rapidly
until the horse becomes ataxic, at which point, ketamine
is administered as a bolus. Alternatively, ketamine can
be mixed with the guaiphenesin, and the mixture given to
effect until recumbency. Although this allows the mixture
to be given somewhat to effect, it is important to administer
approximately half of the mixture rapidly to avoid excessive
ataxia.4

Reversal of alpha-2 agonists

Maintenance of anesthesia

Yohimbine and atipamezole are the most commonly used
alpha-2 antagonists. Because alpha-2 antagonists can induce
serious adverse effects, including hypotension, airway
edema, and excitation, they must be administered slowly.
Yohimbine is a less specific antagonist, and can be used in
doses of 0.025–0.05 mg/kg, given slowly IV. The authors
usually administer yohimbine over 10 minutes. The mean

General anesthesia can be maintained with inhalational, total
intravenous anesthesia or partial intravenous anesthesia.
Inhalational anesthesia is the most common method of
maintaining anesthesia. The MAC of inhalational anesthetics
is likely to be 10%–20% less in geriatric horses. Inhalational
anesthetics generally cause hypotension,94,95 and geriatric
patients may be more prone to hypotension.5

60

submit your manuscript | www.dovepress.com

Dovepress

Veterinary Medicine: Research and Reports 2012:3

Dovepress

Total intravenous anesthesia (TIVA)
Drug kinetics may be altered in geriatric horses, and drug
accumulation may occur during long infusions; thus,
decreasing the infusion rate over time may manage this
problem. Nevertheless, the authors have used TIVA, without
complication, in older horses. These horses may remain
recumbent for longer after TIVA, but the recoveries are
generally more controlled than with inhalational anesthetics.
Another advantage of TIVA is the decreased incidence of
intraoperative hypotension.
Anesthesia can be induced as described above. The
most commonly used drug combination is ketamine and an
alpha-2 agonist with guaiphenesin. The authors suggest that
ketamine (1–1.5 g) and xylazine (500 mg) be added to 1 L
of a 5% solution of guaiphenesin and infused at the rate of
2–3 mL/kg/hour. This mixture is also known as triple drip.
Because guaiphenesin is cleared slowly it may contribute
to weakness in recovery; thus, the authors recommend that
it only be administered for the first hour. Beyond this time,
anesthesia is maintained with ketamine and xylazine diluted
in a balanced electrolyte solution.

Partial intravenous anesthesia (PIVA)
This is the combination of inhalational and intravenous
anesthetics, and has been used successfully by the authors
in geriatric horses. In the authors’ hospital, ketamine
(2–2.5 mg/kg/hour), xylazine (0.25 mg/kg/hour), and lidocaine
(3–6 mg/kg/hour) are used in conjunction with isoflurane at an
end-tidal concentration of 0.5%. A loading dose of lidocaine
(3 mg/kg over 15 minutes) is followed by an infusion of
6 mg/kg/hour for the first hour, and 3 mg/kg/hour in subsequent
hours. Intraoperative analgesia and a decreased incidence of
hypotension are the main advantages of PIVA.

Respiratory support during general
anesthesia in geriatric horses
In horses with recurrent airway obstruction, the medications
used to modify airway resistance and responsiveness, such
as beta-2 agonists, must not be withheld preoperatively.5
Controlled mechanical ventilation is recommended, because
the adaptive active abdominal phase of expiration, in
response to greater airway resistance, is lost under general
anesthesia. These animals are prone to alveolar hyperinflation
and increased intrathoracic pressure, thus, during mechanical
ventilation, the expiratory time should be sufficiently long
to allow for a full expiration.5 Moderate permissive hypercapnea, and use of a pressure-cycled ventilator, in contrast
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to volume-cycled ventilator, may help prevent progressive
hyperinflation of the lung.5 Supporting ventilation and
oxygenation during recovery is also important, and can be
achieved by using an oxygen demand valve.

Anesthetic concerns in geriatric horses
with musculoskeletal disorders
Horses with significant musculoskeletal abnormalities
(eg, osteoarthritis and sarcopenia) are at increased risk of
anesthetic complications. The decrease in metabolic rate
and muscle mass predispose to hypothermia; thus, active
heating may be indicated. Padding and proper positioning
are very important in optimizing the outcome. Assistance
during recovery may be necessary due to muscle weakness
and osteoarthritis.5 The authors routinely use head and tail
ropes to assist recovery in geriatric horses.

Anesthetic monitoring and pain control
in geriatric animals
Monitoring during anesthesia is important because geriatric
horses may have limited physiological reserve. The minimum
anesthetic monitoring includes assessment of anesthetic
depth and indicators of cardiopulmonary function (capillary
refill time, pulse quality, and rhythm). Arterial blood
pressure measurement, preferably a direct measurement, is
recommended. A minimum mean blood pressure of 70 mmHg
should be maintained, using an inotrope (eg, dobutamine),
if necessary. The ECG should be monitored closely due to
the increased incidence of arrhythmias in older horses, and
arterial blood gases analysis monitoring is advisable due to
the increased incident of hypoxemia in this age group.
Control of pain in geriatric animals, especially those
that may suffer from underlying painful conditions such
as musculoskeletal diseases or those that undergo surgical
procedures, has a significant role in assuring a more
favorable anesthetic outcome. Preoperative administration of
nonsteroidal anti-inflammatory drugs, if not contraindicated,
intraoperative administration of analgesics as components
of TIVA or PIVA, and the use of local–regional blocks, are
among the techniques that can be recommended to control
perianesthetic pain and minimize the stress response.
In summary, age-associated physiological changes in
geriatric horses make them prone to anesthetic complications.
However, by administering a balanced anesthesia regimen,
closely monitoring of body systems during anesthesia, and
assisting with recovery, as well as controlling pain, the
anesthetic outcome can be optimized.
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